A Study of Risdiplam (RO7034067) in Adult and Pediatric Participants With Spinal Muscular Atrophy

Clinical trial NCT03032172 · COMPLETED

Trial details

NCT number: NCT03032172
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Spinal Muscular Atrophy

Start date: 2017-03-03
Primary completion: 2025-02-07
Enrollment: 174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.